Market Closed -
Other stock markets
|
5-day change | 1st Jan Change | ||
27.22 BRL | -0.18% | -0.18% | +3.54% |
06-18 | Beiersdorf: gaining share in shrinking China luxury skin care market | RE |
06-12 | Smith & Nephew Launches Pre-Operative Planning, Modeling Services for Robotic-Assisted Surgical System | MT |
Strengths
- The company's profit outlook over the next few years is a strong asset.
- The company's EBITDA/Sales ratio is relatively high and results in high margins before depreciation, amortization and taxes.
- Analysts have a positive opinion on this stock. Average consensus recommends overweighting or purchasing the stock.
- The difference between current prices and the average target price is rather important and implies a significant appreciation potential for the stock.
- Consensus analysts have strongly revised their opinion of the company over the past 12 months.
Weaknesses
- For the last 12 months, analysts have been regularly downgrading their EPS expectations. Analysts predict worse results for the company against their predictions a year ago.
Ratings chart - Surperformance
Sector: Medical Equipment, Supplies & Distribution
1st Jan change | Capi. | Investor Rating | ESG Refinitiv | |
---|---|---|---|---|
+3.54% | 10.82B | - | ||
+13.39% | 129B | A- | ||
-16.57% | 7.12B | C | ||
+41.54% | 5.66B | B+ | ||
-31.48% | 4.14B | C | ||
+8.95% | 3.46B | C- | ||
-19.67% | 2.47B | B- | ||
-16.74% | 1.95B | - | ||
-23.55% | 1.7B | - | ||
-36.63% | 1.46B | C- |
Financials
Valuation
Momentum
Consensus
Business Predictability
Technical analysis
- Stock Market
- Equities
- SN. Stock
- S1NN34 Stock
- Ratings Smith & Nephew plc